
Aiden Y. Lee
Examiner (ID: 746, Phone: (571)270-1440 , Office: P/1718 )
| Most Active Art Unit | 1718 |
| Art Unit(s) | 1718, 1713 |
| Total Applications | 525 |
| Issued Applications | 210 |
| Pending Applications | 69 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9370977
[patent_doc_number] => 20140080850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING AN OMEGA-3 FATTY ACID AND A HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/908911
[patent_app_country] => US
[patent_app_date] => 2013-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13473
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13908911
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/908911 | PHARMACEUTICAL COMPOSITION COMPRISING AN OMEGA-3 FATTY ACID AND A HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME | Jun 2, 2013 | Abandoned |
Array
(
[id] => 10844592
[patent_doc_number] => 08871768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Certain chemical entities, compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 13/897086
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48479
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897086
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/897086 | Certain chemical entities, compositions and methods | May 16, 2013 | Issued |
Array
(
[id] => 9135713
[patent_doc_number] => 20130296428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'REDUCTION OF RISK OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 13/859011
[patent_app_country] => US
[patent_app_date] => 2013-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6014
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859011
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/859011 | Reduction of risk of obesity | Apr 8, 2013 | Issued |
Array
(
[id] => 9004514
[patent_doc_number] => 20130225639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/857465
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8858
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857465
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/857465 | ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPY | Apr 4, 2013 | Abandoned |
Array
(
[id] => 8990482
[patent_doc_number] => 20130217763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY'
[patent_app_type] => utility
[patent_app_number] => 13/847159
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13212
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/847159 | Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality | Mar 18, 2013 | Issued |
Array
(
[id] => 9989848
[patent_doc_number] => 09035052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'Compositions of azimilide dihydrochloride'
[patent_app_type] => utility
[patent_app_number] => 13/840612
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 27583
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13840612
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/840612 | Compositions of azimilide dihydrochloride | Mar 14, 2013 | Issued |
Array
(
[id] => 9108281
[patent_doc_number] => 20130281413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Salicylate Conjugates Useful For Treating Metabolic Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/829266
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 35357
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13829266
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/829266 | Salicylate Conjugates Useful For Treating Metabolic Disorders | Mar 13, 2013 | Abandoned |
Array
(
[id] => 8950000
[patent_doc_number] => 20130195780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Skin Care Products Contianing Anatabine Or Derivative Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/803028
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2506
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13803028
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/803028 | Skin Care Products Contianing Anatabine Or Derivative Thereof | Mar 13, 2013 | Abandoned |
Array
(
[id] => 8904821
[patent_doc_number] => 20130172324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/774869
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 51793
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13774869
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/774869 | METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | Feb 21, 2013 | Abandoned |
Array
(
[id] => 11814880
[patent_doc_number] => 09718821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Pyridopyrimidinone inhibitors of kinases'
[patent_app_type] => utility
[patent_app_number] => 13/773906
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70325
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2901
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13773906
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/773906 | Pyridopyrimidinone inhibitors of kinases | Feb 21, 2013 | Issued |
Array
(
[id] => 8977449
[patent_doc_number] => 20130210879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'FORMULATIONS OF BENDAMUSTINE'
[patent_app_type] => utility
[patent_app_number] => 13/767672
[patent_app_country] => US
[patent_app_date] => 2013-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8086
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13767672
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/767672 | FORMULATIONS OF BENDAMUSTINE | Feb 13, 2013 | Abandoned |
Array
(
[id] => 8842001
[patent_doc_number] => 20130137629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'COMBINATION TREATMENT FOR METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/749135
[patent_app_country] => US
[patent_app_date] => 2013-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6150
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13749135
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/749135 | COMBINATION TREATMENT FOR METABOLIC DISORDERS | Jan 23, 2013 | Abandoned |
Array
(
[id] => 9491700
[patent_doc_number] => 20140142106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'METHOD FOR TREATING PERITONEAL FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/739825
[patent_app_country] => US
[patent_app_date] => 2013-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4285
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13739825
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/739825 | METHOD FOR TREATING PERITONEAL FIBROSIS | Jan 10, 2013 | Abandoned |
Array
(
[id] => 8792677
[patent_doc_number] => 20130109646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'METHOD FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION WITH AN ADENOSINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/722100
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5400
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722100
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/722100 | METHOD FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION WITH AN ADENOSINE DERIVATIVE | Dec 19, 2012 | Abandoned |
Array
(
[id] => 11197203
[patent_doc_number] => 09427398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Parenteral solutions containing metolazone'
[patent_app_type] => utility
[patent_app_number] => 13/717680
[patent_app_country] => US
[patent_app_date] => 2012-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2438
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13717680
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/717680 | Parenteral solutions containing metolazone | Dec 16, 2012 | Issued |
Array
(
[id] => 8815271
[patent_doc_number] => 20130116316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Solid Pharmaceutical Compositions Containing Benzofuran Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/682283
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3931
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682283
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/682283 | Solid Pharmaceutical Compositions Containing Benzofuran Derivatives | Nov 19, 2012 | Abandoned |
Array
(
[id] => 9671693
[patent_doc_number] => 20140235556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'COMPOSITIONS AND METHODS OF TREATING GLIOMAS'
[patent_app_type] => utility
[patent_app_number] => 14/347339
[patent_app_country] => US
[patent_app_date] => 2012-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16941
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347339
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/347339 | Compositions and methods of treating gliomas | Sep 24, 2012 | Issued |
Array
(
[id] => 8768019
[patent_doc_number] => 20130096056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'AMINOTHIAZOLE DERIVATIVES AS HUMAN STEAROYL-COA DESATURASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/620339
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37597
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620339
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620339 | AMINOTHIAZOLE DERIVATIVES AS HUMAN STEAROYL-COA DESATURASE INHIBITORS | Sep 13, 2012 | Abandoned |
Array
(
[id] => 8815280
[patent_doc_number] => 20130116325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING ANHIDROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/603031
[patent_app_country] => US
[patent_app_date] => 2012-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4275
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13603031
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/603031 | COMPOSITIONS AND METHODS FOR TREATING ANHIDROSIS | Sep 3, 2012 | Abandoned |
Array
(
[id] => 8523428
[patent_doc_number] => 20120322836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS AND METHODS FOR STABILIZING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/600083
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6220
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13600083
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/600083 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR STABILIZING THE SAME | Aug 29, 2012 | Abandoned |